In this episode, Andrew Cohen, DMD, who is board certified in dental sleep medicine and a comprehensive restorative dentist, explains how anatomy, behavior, and overall health impacts sleep-related breathing. We discuss common issues like mouth-breathing, teeth grinding, thumb-sucking, and extended pacifier use and how these impact dental health and sleep. For more information, visit the CHOP Sleep Center.   Opinions expressed in this episode are those of Andrew Cohen, DMD, and not necessarily representative of Children's Hospital of Philadelphia.

Craniosynostosis (CS) is a congenital condition characterized by the premature fusion of cranial sutures due to abnormal developmental pathways (Governale et al., 2015). This fusion can lead to increased intracranial pressure, cognitive impairment, and visible skull deformities. Current treatments include helmet therapy and minimally invasive surgical procedures. However, re-craniosynostosis can occur, limiting the long-term effectiveness of surgery. In addition, these procedures are associated with significant financial costs and carry risks such as substantial blood loss. Through the Princeton IIP program, I had the opportunity to research sustainable alternatives for CS treatment.

Daniel P. Kelly, MD, CHOP's Cardiovascular Institute Director, won AHA's 2025 Distinguished Scientist Award for cardiovascular research. Children’s Hospital of Philadelphia (CHOP) is pleased to announce that Daniel P. Kelly, MD, Director of the Cardiovascular Institutes at CHOP and the Perelman School of Medicine at the University of Pennsylvania and a renowned researcher in the field of cardiovascular and metabolic diseases, was presented with the prestigious 2025 Distinguished Scientist Award by the American Heart Association (AHA) at the organization’s Scientific Sessions in New Orleans on Saturday, November 8th. The AHA’s Distinguished Scientist award, established in 2003, celebrates members who have made extraordinary contributions to research in cardiovascular, stroke, and brain health.“I am deeply honored to receive the 2025 Distinguished Scientist award," said Kelly. “Support from the AHA was crucial in launching my research, allowing me to make meaningful contributions to pediatric heart health by fostering connections with fellow scientists and collaborators.”Kelly's research journey began with a focus on rare genetic metabolic disorders that lead to cardiomyopathy and sudden death in children. This evolved into a broader mission to uncover the metabolic roots of heart disease. Among his groundbreaking work, Kelly identified genetic causes affecting mitochondrial fat metabolism, which led to practical newborn screening tests.His research has transitioned from fundamental discoveries to developing new therapies that address metabolic imbalances in heart failure. One of these therapies progressed to human clinical trials, marking a significant milestone in potential heart disease treatments.Kelly has received numerous accolades throughout his career. He is a member of the American Society for Clinical Investigation and the Association of American Physicians, where he served as President in 2022. His previous honors from the AHA include the 1995 Established Investigator Award, the 2008 Basic Cardiovascular Science Council Distinguished Achievement Award, and the 2009 Basic Research Prize.

Podcast Episode · Primary Care Perspectives · 10/28/2025 · 32m

Podcast Episode · Primary Care Perspectives · 10/08/2025 · 29m